Company CVAbout Ipca Laboratories Ltd 
Ipca Laboratories Ltd
Large Cap
Pharmaceuticals & Drugs
Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments. The products of the Company are now sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market.
Company Coordinates
Company Details
48 Kandivli Industrial Estate, Kandivli (West) Mumbai Maharashtra : 400067
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 25.37 Cr
Number of Shares
25.37 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
10-Jan-2022
25.37
25.37
126852109
1
Stock Split
02-Sep-2020
12.69
25.37
500000
2
Conversion of Warrants
21-Apr-2015
12.62
25.24
500
2
Allotment of Equity To Others
21-Apr-2015
12.62
25.24
500
2
Allotment of Equity To Others
30-Jan-2013
12.62
25.24
48750
2
ESOP
30-Jan-2013
12.62
25.24
48750
2
ESOP
15-Jun-2012
12.62
25.23
322704
2
Amalgamation
15-Jun-2012
12.62
25.23
322704
2
Amalgamation
20-Jan-2012
12.58
25.17
121250
2
ESOP
20-Jan-2012
12.58
25.17
121250
2
ESOP
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 33 Schemes (28.55%)
FIIs
Held by 195 FIIs (10.83%)
Promoter with highest holding
Kaygee Investments Private Limited (21.47%)
Highest Public shareholder
Hdfc Mutual Fund - Hdfc Mid-cap Opportunities Fund (8.46%)
Individual Investors Holdings
6.93%
Board of Directors
Management
Designation
Remuneration
Premchand Godha
Chairman / Executive Director
11.27 cr
A K Jain
Managing Director
7.75 cr
A K Jain
Joint Managing Director & CFO
7.75 cr
Anand T Kusre
Independent Director
10.5 lacs
Pranay Godha
ED / MD / CEO / Promoter
5.1 cr
Pranay Godha
Managing Director
5.1 cr
Prashant Godha
Executive Director
4.6 cr
Anand T Kusre
Independent Non Exe. Director
10.5 lacs
Harish P Kamath
Company Sec. & Compli. Officer
0
Prashant Godha
Executive Director
4.6 cr
Manisha Premnath
Independent Non Exe. Director
9.5 lacs
Manisha Premnath
Independent Director
9.5 lacs
Kamal Kishore Seth
Independent Non Exe. Director
14.0 lacs
Kamal Kishore Seth
Independent Director
14.0 lacs
Narendra Mairpady
Independent Non Exe. Director
6.0 lacs
Narendra Mairpady
Independent Director
6.0 lacs
Harish P Kamath
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Others-Purchases
0.84
0%
Others-Purchases
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Formulations
2,695.09
74.18%
Active Pharmaceutical Ingredients/Intermediates
884.56
24.35%
Other Operating Revenues - Export Incentive
42.11
1.16%
Formulations
Formulations
Active Pharmaceutical Ingredients/Intermediates
Active Pharmaceutical Ingredients/Intermediates
Other Operating Revenues - Export Incentive
Other Operating Revenues - Export Incentive
Stock DNARevenue and Profits:
Net Sales:
2,245 Cr
(Quarterly Results - Dec 2024)
Net Profit:
248 Cr
Pharmaceuticals & Drugs
INR 33,749 Cr (Large Cap)
45.00
33
0.31%
0.04
9.16%
4.90
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
